Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
CDNA CareDx Inc
- Stocks
- Healthcare
- NASDAQ: CDNA
Price (delayed)
$20.63
Market cap
$1.15B
P/E Ratio
18.26
Dividend/share
N/A
EPS
$1.13
Enterprise value
$1.08B
CareDx, Inc., headquartered in South San Francisco, California, is a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant
Highlights
CareDx's EPS has soared by 133% YoY and by 13% from the previous quarter
CareDx's net income has soared by 132% YoY and by 12% from the previous quarter
The debt has declined by 10% year-on-year but it has grown by 8% since the previous quarter
The company's quick ratio fell by 10% YoY and by 2.7% QoQ
Key stats
What are the main financial stats of CDNA
Market
Valuations
Earnings
Shares outstanding
55.68M
Market cap
$1.15B
Enterprise value
$1.08B
Price to earnings (P/E)
18.26
Price to book (P/B)
3.01
Price to sales (P/S)
3.29
EV/EBIT
22.74
EV/EBITDA
16.14
EV/Sales
3.13
Revenue
$346.42M
Gross profit
$234.31M
Operating income
$46.73M
Net income
$58.86M
EBIT
$47.64M
EBITDA
$67.12M
Free cash flow
$20.15M
Per share
Balance sheet
Liquidity
EPS
$1.13
EPS diluted
$1.06
Free cash flow per share
$0.36
Book value per share
$6.84
Revenue per share
$6.27
TBVPS
$7.46
Total assets
$489.64M
Total liabilities
$110.29M
Debt
$24.07M
Equity
$379.35M
Working capital
$264.96M
Debt to equity
0.06
Current ratio
4.11
Quick ratio
3.55
Net debt/EBITDA
-0.97
Margins
Efficiency
Dividend
EBITDA margin
19.4%
Gross margin
67.6%
Net margin
17%
Operating margin
13.5%
Return on assets
12.2%
Return on equity
18.2%
Return on invested capital
19.7%
Return on capital employed
11.8%
Return on sales
13.8%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
CDNA stock price
How has the CareDx stock price performed over time
Intraday
1.73%
1 week
7.22%
1 month
3.93%
1 year
43.16%
YTD
-3.64%
QTD
5.58%
Financial performance
How have CareDx's revenue and profit performed over time
Revenue
$346.42M
Gross profit
$234.31M
Operating income
$46.73M
Net income
$58.86M
Gross margin
67.6%
Net margin
17%
CareDx's net income has soared by 132% YoY and by 12% from the previous quarter
The net margin has surged by 125% year-on-year and by 8% since the previous quarter
The operating income has surged by 123% year-on-year and by 15% since the previous quarter
CareDx's operating margin has soared by 118% YoY and by 11% from the previous quarter
Price vs fundamentals
How does CDNA's price correlate with its fundamentals
Growth
What is CareDx's growth rate over time
Valuation
What is CareDx stock price valuation
P/E
18.26
P/B
3.01
P/S
3.29
EV/EBIT
22.74
EV/EBITDA
16.14
EV/Sales
3.13
CareDx's EPS has soared by 133% YoY and by 13% from the previous quarter
The equity has increased by 48% YoY
The stock's price to book (P/B) is 31% less than its 5-year quarterly average of 4.3 and 20% less than its last 4 quarters average of 3.7
The price to sales (P/S) is 49% less than the 5-year quarterly average of 6.4 and 10% less than the last 4 quarters average of 3.6
The revenue has increased by 26% YoY and by 3.8% QoQ
Efficiency
How efficient is CareDx business performance
CDNA's return on assets has surged by 132% year-on-year and by 10% since the previous quarter
The ROE has soared by 132% YoY
The ROIC has soared by 127% YoY and by 13% QoQ
CareDx's ROS has soared by 119% YoY and by 12% from the previous quarter
Dividends
What is CDNA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for CDNA.
Financial health
How did CareDx financials performed over time
CareDx's total liabilities has decreased by 44% YoY and by 2.1% from the previous quarter
The company's quick ratio fell by 10% YoY and by 2.7% QoQ
The debt is 94% smaller than the equity
The equity has increased by 48% YoY
CareDx's debt to equity has decreased by 40% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.